FDA Inspection 1123170 — Kentucky Blood Center Inc.,

Kentucky Blood Center Inc., — FEI 3007689681

The FDA completed an inspection of Kentucky Blood Center Inc., on February 10, 2020 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 10, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lexington, KY (United States)